Apr 12, 2018   SOURCE: PR NewsWire

2-Day Seminar: Process Validation Guidance Requirements - FDA and EU Annex 15 (Boston, MA, United States - May 10-11, 2018)

2-Day Seminar: Process Validation Guidance Requirements - FDA and EU Annex 15 (Boston, MA, United States - May 10-11, 2018)

DUBLIN, April 12, 2018 /PRNewswire/ --

The "Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation): 2-Day Workshop " conference has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This two day, interactive seminar which provides a conduit to enhance your understanding of the Continued Process Verification, will be reviewed in detail: where does it begin; what is included; and, when does it end.

These questions will be addressed within Stage 2 as presented here and include utilization of Process Validation and Phase 1, 2 and 3, where their Guidances blend and where they remain distinct. In particular, Stage 3.

Agenda

Day 01 (8:30 AM - 5:00 PM)

    --  08.30 AM - 09.00 AM: Registration
    --  09.00 AM: Session Start
    --  Introduction, Goals and Objectives, Definitions. Process Validation -
        Its Importance within the Drug Industry
    --  Interaction of the Three Stages with Process Validation
    --  Validation Approaches, cGMPs in Clinical Supply Manufacture, Special
        Manufacturing Situations within Phase 1
    --  The Requirements of Phase 1 Investigational Drug Requirements
    --  Regulatory Strategies for Phase 2 and 3 and their Incorporation within
        Stages 1 and 2

Day 02 (8:30 AM - 4:30 PM)

    --  General Considerations for Process Validation - Stage 2 Process
        Qualifications
    --  Special Considerations for Process Validation - Stage 2
    --  General Considerations for Process Validation - Stage 3 Continued
        Process Verification
    --  A Review of EU Annex 15 and its Comparison to FDA's Process Validation
        Guidance
    --  Concurrent Release of Process Performance Qualification (PPQ) Batches
    --  Analytical Methodology and Process Validation; Warning Letter examples

For more information about this conference visit https://www.researchandmarkets.com/research/65fs2x/2day_seminar?w=5


Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/2-day-seminar-process-validation-guidance-requirements---fda-and-eu-annex-15-boston-ma-united-states---may-10-11-2018-300628835.html

SOURCE Research and Markets